Clinical Trial Update: Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the safety and immunomodulatory effects of SCV 07 as a monotherapy or in combination with ribavirin in noncirrhotic patients with relap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SCV-07 (SCV-07)

Snippet

Sponsor: SciClone Pharmaceuticals | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED